These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effect of LDL-apheresis on a case of Cerebrotendinous Xanthomatosis]. Fukuo Y, Hayama N, Hara K, Terashi A, Seta K. Rinsho Shinkeigaku; 1989 Feb; 29(2):196-201. PubMed ID: 2752648 [Abstract] [Full Text] [Related]
23. Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. Bencze KS, Vande Polder DR, Prockop LD. J Neurol Neurosurg Psychiatry; 1990 Feb; 53(2):166-7. PubMed ID: 2107278 [Abstract] [Full Text] [Related]
30. Cerebrotendinous cholestanolosis in relation to other cerebral xanthomatoses. de Jong JG, van Gent CM, Delleman JW. Clin Neurol Neurosurg; 1977 Feb; 79(4):253-72. PubMed ID: 200389 [Abstract] [Full Text] [Related]
37. Cerebrotendinous xanthomatosis with cholestanolaemia--involvement of five individuals in a Malay family. Othman NH, Rahman SA. Med J Malaysia; 1990 Dec; 45(4):275-80. PubMed ID: 2152046 [Abstract] [Full Text] [Related]
38. Cholestanol deposition in cerebrotendinous xanthomatosis. A possible mechanism. Salen G. Ann Intern Med; 1971 Dec; 75(6):843-51. PubMed ID: 5134895 [No Abstract] [Full Text] [Related]
40. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis. Skrede S, Björkhem I, Buchmann MS, Hopen G, Fausa O. J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]